| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-82 |
| filingDate |
2009-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2012-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2012502885-A |
| titleOfInvention |
N- [4- (1-cyanocyclopentyl) phenyl] -2- (4-pyridylmethyl) amino-3-pyridinecarboxamide salt |
| abstract |
The present invention relates to a salt of N- [4- (1-cyanocyclopentyl) phenyl] -2- (4-pyridylmethyl) amino-3-pyridinecarboxamide, in particular the hydrochloride and mesylate of this compound, and antitumor It relates to the use of said salts in the preparation of a medicine. [Selection figure] None |
| priorityDate |
2008-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |